Results 271 to 280 of about 672,953 (296)
Reply to Letter to the Editor: "Critical Appraisal of Isorhamnetin as a Candidate for Pulmonary Arterial Hypertension Treatment". [PDF]
Liu Y.
europepmc +1 more source
ABSTRACT Background Previous data have implied that percutaneous coronary intervention (PCI) of chronic total occlusions (CTO) is dependent on target vessel. This systematic review and meta‐analysis aimed to investigate if the benefit of CTO revascularization with PCI is dependent on the target vessel.
Emil Skov+4 more
wiley +1 more source
Novel Non‐Hyperemic Coronary Physiology Indices for Vessel Longitudinal Analysis
ABSTRACT Background Physiological pattern of coronary artery disease, whether focal or diffuse, is critical in guiding physicians during the decision‐making process for percutaneous coronary interventions. Aims This study introduces two novel non‐hyperemic coronary physiology indices designed for longitudinal vessel analysis.
Simone Fezzi+13 more
wiley +1 more source
Systematic orientation of outpatients with arterial hypertension
Ângela Maria Geraldo Pierin
openalex
Peripheral venous pressure measurements to evaluate congestion in pulmonary arterial hypertension. [PDF]
Coşkun M+8 more
europepmc +1 more source
ABSTRACT Background Transcatheter aortic valve replacement (TAVR) is increasingly used in patients with bicuspid aortic valve (BAV) stenosis, but there is limited comparative data on balloon‐expandable (BEV) versus self‐expanding valves (SEV) in this population. Aim To compare clinical and hemodynamic outcomes between BEVs and SEVs in patients with BAV
Antros Louca+13 more
wiley +1 more source
Integrated bioinformatics identifies ferroptosis biomarkers and therapeutic targets in idiopathic pulmonary arterial hypertension. [PDF]
Zhang Y+7 more
europepmc +1 more source
ABSTRACT Background Heart failure (HF) and chronic kidney disease (CKD) are common comorbidities among patients undergoing coronary angiography. Both conditions are associated with increased risk of adverse cardiovascular outcomes and mortality. However, the joint prognostic impact of HF and CKD in this patient population remains unclear. Aims We aimed
Jari A. Laukkanen+7 more
wiley +1 more source